Cláudia C. D. Nakabashi

Author

Also Known As

Claudia C. D. Nakabashi, Claudia C. Nakabashi, Claudia C.D. Nakabashi, Claudia Cristina D. Nakabashi, Claudia Nakabashi, Claudia C.D. Nakabashi, Cláudia C. D. Nakabashi, Cláudia C.D. Nakabashi, Cláudia Cristina Doimo Nakabashi, Nakabashi, Claudia C. D.

Publications

618

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de São Paulo Hospital Israelita Albert Einstein Fleury S.A. (Brazil)Johns Hopkins University Duke Medical Center

About

Cláudia C. D. Nakabashi is an author at Universidade Federal de São Paulo specializing in medicine, nuclear medicine, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	15
2	Endocrine Surgery	1	1	15
3	Iodine Deficiency Disorders	1	1	15
4	Nuclear Medicine	1	1	15
5	Radiology	1	1	15

Cláudia C. D. Nakabashi

Publications

548

Citations

H-Index

Page 1

	Year	Citations
A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression Janete M. Cerutti, Rosana Delcelo, Marcelo João Amadei, Journal of Clinical Investigation	2004	178
One Month Is Sufficient for Urinary Iodine to Return to Its Baseline Value After the Use of Water-Soluble Iodinated Contrast Agents in Post-Thyroidectomy Patients Requiring Radioiodine Therapy Rosália do Prado Padovani, Teresa S. Kasamatsu, Cláudia C. D. Nakabashi, Thyroid	2012	124
Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers Janete M. Cerutti, Flávia Roche Moreira Latini, Cláudia C. D. Nakabashi, Clinical Cancer Research	2006	66
Bethesda Classification and Cytohistological Correlation of Thyroid Nodules in a Brazilian Thyroid Disease Center Kassia B Reuters, Maria Conceição Mamone, Elsa S Ikejiri, European Thyroid Journal	2018	34
A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression Janete M. Cerutti, Rosana Delcelo, Marcelo João Amadei, Journal of Clinical Investigation	2004	33
Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma M. Cecilia Martins-Costa, Rui M. B. Maciel, Teresa S. Kasamatsu, Archives of Endocrinology and Metabolism	2017	25
Development of a Sensitive and Specific Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for Blood Thyroglobulin Messenger Ribonucleic Acid in the Follow-Up of Patients with Differentiated Thyroid Carcinoma Valter Tadeu Boldarine, Rui M. B. Maciel, Gustavo S. Guimarães, The Journal of Clinical Endocrinology & Metabolism	2010	22
A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy Carolina Castro Porto Silva Janovsky, Rui M. B. Maciel, Cleber Camacho, European Thyroid Journal	2015	21
Basal Serum Thyroglobulin Measured by a Second-Generation Assay Is Equivalent to Stimulated Thyroglobulin in Identifying Metastases in Patients with Differentiated Thyroid Cancer with Low or Intermediate Risk of Recurrence Cláudia C. D. Nakabashi, Teresa S. Kasamatsu, Felipe Crispim, European Thyroid Journal	2014	19
One Month is Sufficient for Urinary Iodine to Return to its Baseline Value after the Use of Water Soluble Iodinated Contrast Agents in Post-Thyroidectomy Patients Requiring Radioiodine Therapy Rosália do Prado Padovani, Teresa S. Kasamatsu, Cláudia C. D. Nakabashi, Thyroid UrologyIodine Deficiency DisordersThyroid DiseaseBaseline ValueRadiopharmaceutical Therapy	2012	15

Page 1